Understanding the widespread use of veterinary ivermectin for Chagas disease, underlying factors and implications for the COVID-19 pandemic: a convergent mixed-methods study

dc.contributor.authorBoris Michel
dc.contributor.authorMiriam Navarro
dc.contributor.authorMichael Pritsch
dc.contributor.authorJeremy Douglas Du Plessis
dc.contributor.authorJonathan P. Shock
dc.contributor.authorEva‐Maria Schwienhorst-Stich
dc.contributor.authorJanina Zirkel
dc.contributor.authorHanna Schrader
dc.contributor.authorClaudia Saavedra Irala
dc.contributor.authorGonzalo Rubilar
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T16:03:44Z
dc.date.available2026-03-22T16:03:44Z
dc.date.issued2022
dc.descriptionCitaciones: 2
dc.description.abstractSocial determinants of health, the unavailability of treatment and a wonder drug image might contribute to the phenomenon of vet-IVM.
dc.identifier.doi10.1136/bmjopen-2021-058572
dc.identifier.urihttps://doi.org/10.1136/bmjopen-2021-058572
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/56016
dc.language.isoen
dc.publisherBMJ
dc.relation.ispartofBMJ Open
dc.sourceCentro de Información y Desarrollo de la Mujer
dc.subjectMedicine
dc.subjectPandemic
dc.subjectFocus group
dc.subjectDisease
dc.subjectIvermectin
dc.subjectChagas disease
dc.subjectPublic health
dc.subjectBiostatistics
dc.subjectQualitative research
dc.subjectEnvironmental health
dc.titleUnderstanding the widespread use of veterinary ivermectin for Chagas disease, underlying factors and implications for the COVID-19 pandemic: a convergent mixed-methods study
dc.typearticle

Files